![](/img/cover-not-exists.png)
Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone
Adeyanju, Oluwaseun A., Falodun, Timothy O., Fabunmi, Oyesanmi A., Olatunji, Lawrence A., Soladoye, Ayodele O.Volume:
310
Journal:
Chemico-Biological Interactions
DOI:
10.1016/j.cbi.2019.108742
Date:
September, 2019
File:
PDF, 1.30 MB
2019